These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6751079)

  • 41. Stability and sterility of cimetidine admixtures frozen in minibags.
    Walker SE; Paton TW; Fabian TM; Liu CC; Coates PE
    Am J Hosp Pharm; 1981 Jun; 38(6):881-3. PubMed ID: 7246565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consequences of inadvertent microbial contamination of dextrose solutions.
    Mendie UE; Hugbo PG; Nasipuri RN
    West Afr J Med; 1996; 15(4):190-5. PubMed ID: 9020594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
    Cummings DS; Park MK; Howard AB
    Am J Hosp Pharm; 1982 Oct; 39(10):1685-7. PubMed ID: 7148843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
    Johnson CE; Jacobson PA; Chan E
    Am J Hosp Pharm; 1994 Feb; 51(4):503-8. PubMed ID: 8017417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 48. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sterility testing of home and inpatient parenteral nutrition solutions.
    Bronson MH; Stennett DJ; Egging PK
    JPEN J Parenter Enteral Nutr; 1988; 12(1):25-8. PubMed ID: 3125353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The incubation period in sterility testing.
    Bathgate H; Lazzari D; Cameron H; McKay D
    J Parenter Sci Technol; 1993; 47(5):254-7. PubMed ID: 8263662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal sampling time after preparation of platelet concentrates for detection of bacterial contamination by quantitative real-time polymerase chain reaction.
    Mohammadi T; Pietersz RN; Scholtalbers LA; Vandenbroucke-Grauls CM; Savelkoul PH; Reesink HW
    Vox Sang; 2005 Nov; 89(4):208-14. PubMed ID: 16262753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors affecting the availability of diazepam stored in plastic bags and administered through intravenous sets.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1983 Mar; 40(3):417-23. PubMed ID: 6846350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures.
    Zellmer WA
    Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972
    [No Abstract]   [Full Text] [Related]  

  • 55. Sterility testing of platelet concentrates prepared from deliberately infected blood donations.
    Mohr H; Lambrecht B; Bayer A; Spengler HP; Nicol SB; Montag T; Müller TH
    Transfusion; 2006 Mar; 46(3):486-91. PubMed ID: 16533294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between length of time and contamination in open intravenous solutions.
    Amonsen S; Gren JE
    Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method.
    Khuu HM; Patel N; Carter CS; Murray PR; Read EJ
    Transfusion; 2006 Dec; 46(12):2071-82. PubMed ID: 17176318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability of fluconazole in injectable solutions.
    Hunt-Fugate AK; Hennessey CK; Kazarian CM
    Am J Hosp Pharm; 1993 Jun; 50(6):1186-7. PubMed ID: 8517459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.